PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation

• Status: Completed
• Trial end date: 2019-11-29
• Target enrollment: 0
• Participant gender: All

Summary

A randomized controlled split-face pilot study was planned to investigate the preventive effect of tretinoin 0.05% cream on hyperpigmentation during phototherapy in patients with vitiligo.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The Catholic University of Korea
• Treatments: Tretinoin

Criteria

Inclusion Criteria:

• Age: older than 19

• A patient with stable non-segmental vitiligo

• A patient with symmetrical vitiligo lesions on face

• A patient with the willingness to comply with the study protocol during the study period and capable of complying with it.

• A patient who signed the informed consent prior to the participation of the study and who understands that he/she has a right to withdrawal from participation in the study at any time without any disadvantages.

Exclusion Criteria:

• Age: lower than 20

• A pregnant or lactating patient

• A patient with active or spreading vitiligo

• A patient who cannot understand the study or who does not sign the informed consent

• Women of childbearing potential not using an effective method of contraception properly